AstraZeneca (AZN) Earnings Date, Estimates & Call Transcripts $72.44 -0.16 (-0.23%) As of 09:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AstraZeneca Latest Earnings SummaryUpcoming Q1 Earnings DateApr. 24Before Market OpensEstimatedActual EPS (Feb. 6) $1.05 Missed By -$0.05 Consensus EPS (Feb. 6) $1.10 AstraZeneca released Q4 2024 earnings on February 6, 2025, reporting an EPS of $1.05, which missed analysts' consensus estimates of $1.10 by $0.05. With a trailing EPS of $2.26 and a P/E Ratio of 32.04, AstraZeneca's earnings are expected to grow 10.86% next year, from $4.51 to $5.00 per share. Conference CallConference Call TranscriptAZN Upcoming EarningsAstraZeneca's next earnings date is estimated for Thursday, April 24, 2025, based off prior year's reporting schedules. Get AstraZeneca Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AstraZeneca and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAZN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AZN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads AstraZeneca Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20252$1.07$1.11$1.09 Q2 20252$1.10$1.11$1.11 Q3 20252$1.13$1.15$1.14 Q4 20252$1.11$1.21$1.16 FY 20258$4.41$4.58$4.50 Q1 20261$1.16$1.16$1.16 Q2 20261$1.20$1.20$1.20 Q3 20261$1.27$1.27$1.27 Q4 20261$1.35$1.35$1.35 FY 20264$4.98$4.98 $4.98 Remove Ads AstraZeneca Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/24/2025(Estimated)-------2/6/2025Q4 2024$1.10$1.05 -$0.05$0.48$14.19B-11/12/2024Q3 2024$1.01$1.04+$0.03$1.62$13.08B$13.57B7/25/2024Q2 2024$0.98$0.99+$0.01$1.36$12.62B$12.45B4/25/2024Q1 2024$0.95$1.03+$0.08$1.36$11.92B$12.68B2/8/2024Q4 2023$0.74$0.73 -$0.01$1.15$12.07B$12.02B11/8/2023Q3 2023$0.84$0.87+$0.03$1.30$11.55B$11.49B7/28/2023Q2 2023$0.97$1.08+$0.11$1.57$11.06B$11.42B4/27/2023Q1 2023$0.86$0.96+$0.10$1.34$10.80B$10.88B AstraZeneca Earnings - Frequently Asked Questions When is AstraZeneca's earnings date? AstraZeneca has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 24th, 2025 based off last year's report dates. Learn more on AZN's earnings history. Did AstraZeneca beat their earnings estimates last quarter? In the previous quarter, AstraZeneca (NASDAQ:AZN) missed the analysts' consensus estimate of $1.10 by $0.05 with a reported earnings per share (EPS) of $1.05. Learn more on analysts' earnings estimate vs. AZN's actual earnings. How can I listen to AstraZeneca's earnings conference call? The conference call for AstraZeneca's latest earnings report can be listened to online. Listen to Conference Call How can I read AstraZeneca's conference call transcript? The conference call transcript for AstraZeneca's latest earnings report can be read online. Read Transcript How much revenue does AstraZeneca generate each year? AstraZeneca (NASDAQ:AZN) has a recorded annual revenue of $54.07 billion. How much profit does AstraZeneca generate each year? AstraZeneca (NASDAQ:AZN) has a recorded net income of $7.04 billion. AZN has generated $2.26 earnings per share over the last four quarters. What is AstraZeneca's price-to-earnings ratio? AstraZeneca (NASDAQ:AZN) has a trailing price-to-earnings ratio of 32.12 and a forward price-to-earnings ratio of 16.10. The price/earnings-to-growth ratio is 1.42. What is AstraZeneca's EPS forecast for next year? AstraZeneca's earnings are expected to grow from $4.51 per share to $5.00 per share in the next year, which is a 10.86% increase. More Earnings Resources from MarketBeat Related Companies NVO Earnings Results NVS Earnings Results SNY Earnings Results GSK Earnings Results TAK Earnings Results ARGX Earnings Results ONC Earnings Results BNTX Earnings Results TEVA Earnings Results SMMT Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio? Remove Ads This page (NASDAQ:AZN) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts